Evotec slumps as Halozyme withdraws buyout offer

Halozyme Therapeutics

22/11/2024 13:56

** Evotec's  EVTG.DE  shares drop around 16% in volume spike
after biotech company Halozyme  HALO.O  said it withdrew its
offer to acquire the German drug development company
    ** If losses hold Evotec's shares will see their worst day
since July; about 1.5 million shares changed hands so far today,
around 63% of their 30-day moving average full-day volume
    ** The stock falls to the bottom of Germany's small-cap
index  .SDAXI 

 (Reporting by Tristan Veyet)
 ((Tristan.chabba@thomsonreuters.com))